目的 了解孕妇B族链球菌（group B Streptococcus，GBS）定植及新生儿早发型GBS疾病（early-onset GBS disease，GBS-EOD）的发生情况，并探讨GBS定植孕妇的子代发生GBS-EOD的影响因素。 方法 前瞻性纳入2019年5月1日至2020年4月30日在厦门市妇幼保健院、首都医科大学附属北京妇产医院和漳州正兴医院建档的16 384例孕妇及其分娩的16 634例新生儿作为研究对象。各研究中心采用统一的GBS筛查时间、培养方法和产时抗生素预防（intrapartum antibiotic prophylaxis，IAP）适应证，调查孕妇GBS定植率和新生儿GBS-EOD发生率，并应用多因素logistic回归分析评估GBS定植孕妇的子代发生GBS-EOD的影响因素。 结果 3所医院妊娠晚期孕妇GBS培养阳性率为11.29%（1 850/16 384），新生儿GBS-EOD发生率为0.96‰（16/16 634）。GBS阳性组孕妇分娩活产儿收住院率高于GBS阴性组（P<0.05）。GBS阳性组孕妇分娩活产儿的GBS-EOD发生率［6.38‰（12/1 881）］高于GBS阴性组［0.27‰（4/14 725）］（P<0.05）。多因素logistic回归分析显示，胎盘拭子培养GBS阳性和新生儿出生时胃液培养GBS阳性是GBS定植孕妇子代发生GBS-EOD的独立预测因素（P<0.05），而充分IAP为保护因素（P<0.05）。 结论 孕妇妊娠晚期GBS定植对其子代有不良影响。明确孕妇产前GBS定植状态，并依据IAP适应证给予充分IAP是减少其子代发生GBS-EOD的重要措施。 引用格式:
Abstract
Objective To investigate the incidence of maternal group B Streptococcus (GBS) colonization and neonatal early-onset GBS disease (GBS-EOD), and to study the factors associated with the development of GBS-EOD in the offspring of pregnant women with GBS colonization. Methods A total of 16 384 pregnant women and 16 634 neonates delivered by them were enrolled prospectively who had medical records in Xiamen Maternal and Child Care Hospital, Beijing Obstetrics and Gynecology Hospital of Capital Medical University, and Zhangzhou Zhengxing Hospital from May 1, 2019 to April 30, 2020. Unified GBS screening time, culture method, and indication for intrapartum antibiotic prophylaxis (IAP) were adopted in the three hospitals. The incidence rates of maternal GBS colonization and neonatal GBS-EOD were investigated. A multivariate logistic regression analysis was used to identify the factors associated with the development of GBS-EOD in the offspring of pregnant women with GBS colonization. Results In these three hospitals, the positive rate of GBS culture among the pregnant women in late pregnancy was 11.29% (1 850/16 384), and the incidence rate of neonatal GBS-EOD was 0.96‰ (16/16 634). The admission rate of live infants born to the GBS-positive pregnant women was higher than that of those born to the GBS-negative ones (P<0.05). The live infants born to the GBS-positive pregnant women had a higher incidence rate of GBS-EOD than those born to the GBS-negative ones [6.38‰ (12/1 881) vs 0.27‰ (4/14 725), P<0.05]. The multivariate logistic regression analysis showed that placental swabs positive for GBS and positive GBS in neonatal gastric juice at birth were independent predictive factors for the development of GBS-EOD (P<0.05), while adequate IAP was a protective factor (P<0.05) in the offspring of pregnant women with GBS colonization. Conclusions GBS colonization of pregnant women in late pregnancy has adverse effects on their offspring. It is important to determine prenatal GBS colonization status of pregnant women and administer with adequate IAP based on the indications of IAP to reduce the incidence of neonatal GBS-EOD. Citation:
关键词
B族溶血性链球菌疾病 /
细菌定植 /
产时抗生素预防 /
多中心研究 /
新生儿
Key words
Group B Streptococcus disease /
Bacterial colonization /
Intrapartum antibiotic prophylaxis /
Multicenter study /
Neonate
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
1 Raabe VN, Shane AL. Group B Streptococcus (Streptococcus agalactiae)[J]. Microbiol Spectr, 2019, 7(2): GPP3-0007-2018. PMID: 30900541. PMCID: PMC6432937. DOI: 10.1128/microbiolspec.GPP3-0007-2018.
2 Prevention of group B Streptococcal early-onset disease in newborns: ACOG committee opinion, number 797[J]. Obstet Gynecol, 2020, 135(2): e51-e72. PMID: 31977795. DOI: 10.1097/AOG.0000000000003668.
3 Queensland Clinical Guidelines. Early onset group B Streptococcal disease[EB/OL]. (2020-04-20)[2020-12-25]. https://www.health.qld.gov.au/__data/assets/pdf_file/0026/626732/g-gbs.pdf.
4 Zhu Y, Huang J, Lin XZ, et al. Group B Streptococcus colonization in late pregnancy and invasive infection in neonates in China: a population-based 3-year study[J]. Neonatology, 2019, 115(4): 301-309. PMID: 30808831. DOI: 10.1159/000494133.
5 Ji WJ, Liu HY, Madhi SA, et al. Clinical and molecular epidemiology of invasive group B Streptococcus disease among infants, China[J]. Emerg Infect Dis, 2019, 25(11): 2021-2030. PMID: 31600132. PMCID: PMC6810193. DOI: 10.3201/eid2511.181647.
6 Garg S, Tin W. Remington and Klein's infectious diseases of the fetus and newborn infant[J]. Semin Fetal Neonatal Med, 2015, 20(6): 442. DOI: 10.1016/j.siny.2015.09.002.
7 Puopolo KM, Lynfield R, Cummings JJ, et al. Management of infants at risk for group B Streptococcal disease[J]. Pediatrics, 2019, 144(2): e20191881. PMID: 31285392 DOI: 10.1542/peds.2019-1881.
8 时春艳, 赵扬玉, 范玲, 等. 实时聚合酶链反应技术检测妊娠晚期孕妇B族溶血性链球菌的多中心研究[J]. 中华围产医学杂志, 2014, 17(6): 361-364. DOI: 10.3760/cma.j.issn.1007-9408.2014.06.004.
9 Lu B, Li D, Cui Y, et al. Epidemiology of group B Streptococcus isolated from pregnant women in Beijing, China[J]. Clin Microbiol Infect, 2014, 20(6): O370-O373. PMID: 24118553. DOI: 10.1111/1469-0691.12416.
10 冀云鹏, 周雪原, 王杰, 等. 呼和浩特地区妊娠晚期孕妇生殖道B族链球菌感染对妊娠结局的影响[J]. 中国妇产科临床杂志, 2017, 18(2): 162-163. DOI: 10.13390/j.issn.1672-1861.2017.02.020.
11 吴丽娟, 王飞玲, 邹建话, 等. 妊娠晚期B族链球菌筛查对妊娠结局的影响[J]. 中华妇产科杂志, 2019, 54(3): 154-159. PMID: 30893715. DOI: 10.3760/cma.j.issn.0529-567x.2019.03.003.
12 Lawn JE, Bianchi-Jassir F, Russell NJ, et al. Group B Streptococcal disease worldwide for pregnant women, stillbirths, and children: why, what, and how to undertake estimates?[J]. Clin Infect Dis, 2017, 65(suppl_2): S89-S99. PMID: 29117323. PMCID: PMC5850012. DOI: 10.1093/cid/cix653.
13 Wu BQ, Su JZ, Li L, et al. Phenotypic and genetic differences among group B Streptococcus recovered from neonates and pregnant women in Shenzhen, China: 8-year study[J]. BMC Microbiol, 2019, 19(1): 185. PMID: 31395013. PMCID: PMC6688368. DOI: 10.1186/s12866-019-1551-2.
14 Vornhagen J, Adams Waldorf KM, Rajagopal L. Perinatal group B Streptococcal infections: virulence factors, immunity, and prevention strategies[J]. Trends Microbiol, 2017, 25(11): 919-931. PMID: 28633864. PMCID: PMC5650539. DOI: 10.1016/j.tim.2017.05.013.
15 Nanduri SA, Petit S, Smelser C, et al. Epidemiology of invasive early-onset and late-onset group B Streptococcal disease in the United States, 2006 to 2015: multistate laboratory and population-based surveillance[J]. JAMA Pediatr, 2019, 173(3): 224-233. PMID: 30640366. PMCID: PMC6439883. DOI: 10.1001/jamapediatrics.2018.4826.
16 Matsubara K, Hoshina K, Kondo M, et al. Group B Streptococcal disease in infants in the first year of life: a nationwide surveillance study in Japan, 2011-2015[J]. Infection, 2017, 45(4): 449-458. PMID: 28236250. DOI: 10.1007/s15010-017-0995-2.
17 Royal College of Obstetricians and Gynaecologists. Prevention of early-onset neonatal group B Streptococcal disease: green-top guideline No. 36[J]. BJOG, 2017, 124(12): e280-e305. PMID: 28901693. DOI: 10.1111/1471-0528.14821.
18 He Y, Du WX, Jiang HY, et al. Multiplex cytokine profiling identifies interleukin-27 as a novel biomarker for neonatal early onset sepsis[J]. Shock, 2017, 47(2): 140-147. PMID: 27648693. DOI: 10.1097/SHK.0000000000000753.
19 Berner R. Group B Streptococcus vaccines: one step further[J]. Lancet Infect Dis, 2021, 21(2): 158-160. PMID: 32891192. PMCID: PMC7470735. DOI: 10.1016/S1473-3099(20)30451-5.
基金
福建省科技计划引导性项目（2018D0011）；厦门市科技计划重大专项立项（3502Z20171006）。
PDF(645 KB)
